New drug shows promise for painful skin disease
NCT ID NCT03619902
Summary
This study tested whether a medication called imsidolimab (ANB019) could help adults with severe generalized pustular psoriasis, a rare and painful skin condition. Eight participants received the drug to see if it reduced their skin lesions, pustules, and other symptoms. Researchers measured improvements in skin appearance, quality of life, and safety over 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 100
Ann Arbor, Michigan, 48109, United States
-
Site 101
Indianapolis, Indiana, 46250, United States
-
Site 102
Encino, California, 91436, United States
-
Site 104
Miami, Florida, 33316, United States
-
Site 105
Largo, Florida, 33771, United States
-
Site 201
London, United Kingdom
-
Site 202
Salford, United Kingdom
-
Site 203
Newcastle upon Tyne, United Kingdom
-
Site 301
Rzeszów, 35-055, Poland
-
Site 302
Lodz, Poland
-
Site 303
Lodz, 90-436, Poland
-
Site 304
Olsztyn, 10-229, Poland
-
Site 501
Seoul, 03722, South Korea
Conditions
Explore the condition pages connected to this study.